Prognostic effect of systemic immune-inflammation index (SII) in 987 patients with advanced/metastatic urinary tract carcinoma (mUTC) treated with atezolizumab in the real-world global SAUL study

Autor:	Mego, M. Huddart, R. A. Voortman, J. Ong, M. Gedye, C. and Gurney, H. Fay, A. P. Bamias, A. Mellado Gonzalez, B. and Loriot, Y. Merseburger, A. S. Castellano Gauna, D. de Ducla, S. Pavlova, J. Fear, S. Sternberg, C. N.
Jazyk:	angličtina
Rok vydání:	2020
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______2127::af75a44fc544222a796d5f2d5195c714 https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3192232 Zobrazit plný text záznamu